Nutrition

Best Berberine Patch for Transdermal Metabolic Support: NuraPatch Cited in Industry Analysis as Consumer Interest in Botanical Weight Management Options Grows

Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic…

3 days ago

Best Peptides for Skin Care: Injectable vs Topical Delivery Methods – RenuviaRX Consumer Analysis

January 2026 Wellness Season: Glutathione Tripeptide Therapy, Cellular Skin Support Mechanisms, and Telehealth Access Pathways for Injectable Peptide OptionsSHERIDAN, WY,…

3 days ago

DR. ANDREW WEIL AND DAUGHTER DIANA WEIL UPDATE ANTI-INFLAMMATORY FOOD PYRAMID FOR 2026 AFTER 20 YEARS

The refreshed Dr. Weil's Anti-Inflammatory Food Pyramid™ modernizes one of the best-ranked diets by U.S. News & World Report and…

5 days ago

Purina Spotlights Next Generation of Pet Care Innovation with 2026 Pet Care Innovation Prize Winners

Purina awards five startups advancing pet health, wellness and veterinary care with mentorship, $25,000 in funding and the chance to…

5 days ago

New Digital MSK Platform Already has 100+ Million Eligible Members and Offers Savings Upwards of 50-70% Compared to Many Other Digital MSK Offerings!

Solution Provides Self-Guided Tools Broadening Member Options for RecoverySAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- American Specialty Health (ASH), a leader…

5 days ago

Aqua Sculpt Reviews: Breakthrough Hydro-Nutrient Complex Targets Deep Tissue Hydration and Metabolic Sculpting

ST. PETERSBURG, FL / ACCESS Newswire / January 8, 2026 / SummaryAqua Sculpt has emerged as a significant topic of…

5 days ago

Cellev8 Nutrition Welcomes Dr. Guangshuo “Alan” Zhu, MD to Its Board of Directors

WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant…

5 days ago

CorMedix Therapeutics Announces Leadership and Board Updates

BERKELEY HEIGHTS, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

5 days ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

‒ Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒ ‒ FY 2025 Unaudited Pro Forma Net Revenue of…

5 days ago

AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)

Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated in the…

5 days ago